Sector Gamma As Vir Biotechnology, Inc. Transaction History

Sector Gamma As

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 06, 2023	SELL	$9.14 - $24.62 $17,073 - $45,990	-1,868 Reduced 1.24%	148,538 $1.39 Million
Q2 2023 Aug 09, 2023	BUY	$23.2 - $27.29 $112,775 - $132,656	4,861 Added 3.34%	150,406 $3.69 Million
Q1 2023 May 12, 2023	BUY	$22.26 - $30.85 $1.24 Million - $1.72 Million	55,737 Added 62.06%	145,545 $3.39 Million
Q3 2022 Nov 09, 2022	SELL	$18.26 - $31.1 $372,777 - $634,906	-20,415 Reduced 18.52%	89,808 $1.73 Million
Q2 2022 Aug 05, 2022	BUY	$19.08 - $26.7 $572,400 - $801,000	30,000 Added 37.4%	110,223 $2.81 Million
Q1 2022 May 06, 2022	BUY	$21.19 - $40.01 $767,565 - $1.45 Million	36,223 Added 82.33%	80,223 $2.06 Million
Q4 2021 Feb 08, 2022	BUY	$30.97 - $54.03 $1.36 Million - $2.38 Million	44,000 New	44,000 $1.84 Million

219

87.4M

127K

1.19M

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $922M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

Get notified when there are updates to the investment portfolio of Sector Gamma As, based on Form 13F filings with the SEC.

Stay updated on Sector Gamma As with notifications on news.